{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T14:03:55Z","timestamp":1775916235419,"version":"3.50.1"},"posted":{"date-parts":[[2024,3,28]]},"group-title":"In Review","reference-count":71,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,3,14]]},"abstract":"<title>Abstract<\/title>\n        <p>The pathophysiological mechanisms driving disease progression of frontotemporal lobar degeneration (FTLD) and corresponding biomarkers are not fully understood. We leveraged aptamer-based proteomics (&gt;\u20094,000 proteins) to identify dysregulated communities of co-expressed cerebrospinal fluid proteins in 116 adults carrying autosomal dominant FTLD mutations (<italic>C9orf72<\/italic>, <italic>GRN<\/italic>, <italic>MAPT<\/italic>) compared to 39 noncarrier controls. Network analysis identified 31 protein co-expression modules. Proteomic signatures of genetic FTLD clinical severity included increased abundance of RNA splicing (particularly in <italic>C9orf72<\/italic> and <italic>GRN<\/italic>) and extracellular matrix (particularly in <italic>MAPT<\/italic>) modules, as well as decreased abundance of synaptic\/neuronal and autophagy modules. The generalizability of genetic FTLD proteomic signatures was tested and confirmed in independent cohorts of 1) sporadic progressive supranuclear palsy-Richardson syndrome and 2) frontotemporal dementia spectrum syndromes. Network-based proteomics hold promise for identifying replicable molecular pathways in adults living with FTLD. \u2018Hub\u2019 proteins driving co-expression of affected modules warrant further attention as candidate biomarkers and therapeutic targets.<\/p>","DOI":"10.21203\/rs.3.rs-4103685\/v1","type":"posted-content","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T03:09:35Z","timestamp":1711595375000},"source":"Crossref","is-referenced-by-count":3,"title":["Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1351-6183","authenticated-orcid":false,"given":"Rowan","family":"Saloner","sequence":"first","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3903-9805","authenticated-orcid":false,"given":"Adam","family":"Staffaroni","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2947-7606","authenticated-orcid":false,"given":"Eric","family":"Dammer","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-2944","authenticated-orcid":false,"given":"Erik C.B.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Paolillo","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Wise","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Heuer","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Forsberg","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Argentina Lario","family":"Lago","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Webb","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Vogel","sequence":"additional","affiliation":[{"name":"Lund University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Santillo","sequence":"additional","affiliation":[{"name":"Lund University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-7286","authenticated-orcid":false,"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[{"name":"Lund University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Kramer","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Miller","sequence":"additional","affiliation":[{"name":"University of California San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyao","family":"Li","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research, Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Loureiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3917-0181","authenticated-orcid":false,"given":"Rajeev","family":"Sivasankaran","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Worringer","sequence":"additional","affiliation":[{"name":"Novartis (United States)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-624X","authenticated-orcid":false,"given":"Nicholas","family":"Seyfried","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7274-2634","authenticated-orcid":false,"given":"Jennifer","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"UCSF"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Seeley","sequence":"additional","affiliation":[{"name":"University of California at San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3570-9143","authenticated-orcid":false,"given":"Salvatore","family":"Spina","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6809-0618","authenticated-orcid":false,"given":"Lea","family":"Grinberg","sequence":"additional","affiliation":[{"name":"University of California at San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8304-6711","authenticated-orcid":false,"given":"Lawren","family":"VandeVrede","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Ljubenkov","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ece","family":"Bayram","sequence":"additional","affiliation":[{"name":"University of California, San Diego"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Bozoki","sequence":"additional","affiliation":[{"name":"University of North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0543-0228","authenticated-orcid":false,"given":"Danielle","family":"Brushaber","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciaran","family":"Considine","sequence":"additional","affiliation":[{"name":"Vanderbilt University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5133-5538","authenticated-orcid":false,"given":"Gregory","family":"Day","sequence":"additional","affiliation":[{"name":"Mayo Clinic in Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5958-3445","authenticated-orcid":false,"given":"Bradford","family":"Dickerson","sequence":"additional","affiliation":[{"name":"Harvard University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7396-1633","authenticated-orcid":false,"given":"Kimiko","family":"Domoto-Reilly","sequence":"additional","affiliation":[{"name":"University of Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelley","family":"Faber","sequence":"additional","affiliation":[{"name":"Indiana University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6195-3241","authenticated-orcid":false,"given":"Douglas","family":"Galasko","sequence":"additional","affiliation":[{"name":"UC San Diego"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-3450","authenticated-orcid":false,"given":"Daniel","family":"Geschwind","sequence":"additional","affiliation":[{"name":"UCLA Health System and David Geffen School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6680-6731","authenticated-orcid":false,"given":"Nupur","family":"Ghoshal","sequence":"additional","affiliation":[{"name":"Washington University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neill","family":"Graff-Radford","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chadwick","family":"Hales","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9703-2265","authenticated-orcid":false,"given":"Lawrence","family":"Honig","sequence":"additional","affiliation":[{"name":"Columbia University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8017-0856","authenticated-orcid":false,"given":"Ging-Yuek","family":"Hsiung","sequence":"additional","affiliation":[{"name":"University of British Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Huey","sequence":"additional","affiliation":[{"name":"Columbia University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kornak","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Kremers","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1163-5584","authenticated-orcid":false,"given":"Maria","family":"Lapid","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzee","family":"Lee","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3485-3445","authenticated-orcid":false,"given":"Irene","family":"Litvan","sequence":"additional","affiliation":[{"name":"UCSD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey","family":"McMillan","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Pennsylvania, Philadelphia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6441-7989","authenticated-orcid":false,"given":"Mario","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toji","family":"Miyagawa","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Pantelyat","sequence":"additional","affiliation":[{"name":"Johns Hopkins University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4467-7406","authenticated-orcid":false,"given":"Belen","family":"Pascual","sequence":"additional","affiliation":[{"name":"Houston Methodist"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Paulson","sequence":"additional","affiliation":[{"name":"University of Michigan\u2013Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Petrucelli","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Pressman","sequence":"additional","affiliation":[{"name":"University of Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Ramos","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katya","family":"Rascovsky","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1810-9763","authenticated-orcid":false,"given":"Erik","family":"Roberson","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo","family":"Savica","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1857-928X","authenticated-orcid":false,"given":"Allison","family":"Snyder","sequence":"additional","affiliation":[{"name":"National Institutes of Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Campbell","family":"Sullivan","sequence":"additional","affiliation":[{"name":"University of Texas Health San Antonio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5944-8497","authenticated-orcid":false,"given":"Carmela","family":"Tartaglia","sequence":"additional","affiliation":[{"name":"University of Toronto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9645-2615","authenticated-orcid":false,"given":"Marijne","family":"Vandebergh","sequence":"additional","affiliation":[{"name":"University of Antwerp"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4153-8187","authenticated-orcid":false,"given":"Bradley","family":"Boeve","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howie","family":"Rosen","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Rojas","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Boxer","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlin","family":"Casaletto","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","article-title":"Frontotemporal dementia","volume":"386","author":"Bang J","year":"2015","unstructured":"Bang J, Spina S, Miller BL (2015) Frontotemporal dementia. Lancet 386:1672\u20131682","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12031-011-9538-y","article-title":"Estimating the number of persons with frontotemporal lobar degeneration in the US population","volume":"45","author":"Knopman DS","year":"2011","unstructured":"Knopman DS, Roberts RO (2011) Estimating the number of persons with frontotemporal lobar degeneration in the US population. J Mol Neurosci 45:330\u2013335","journal-title":"J Mol Neurosci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/jnc.13588","article-title":"Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies","volume":"138","author":"Mackenzie IRA","year":"2016","unstructured":"Mackenzie IRA, Neumann M (2016) Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies. J Neurochem 138:54\u201370","journal-title":"J Neurochem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e2296","DOI":"10.1212\/WNL.0000000000011848","article-title":"Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration","volume":"96","author":"Rojas JC","year":"2021","unstructured":"Rojas JC et al (2021) Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration. Neurology 96:e2296\u2013e2312","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/alz.12004","article-title":"Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS","volume":"16","author":"Rosen HJ","year":"2020","unstructured":"Rosen HJ, Boeve BF, Boxer AL (2020) Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS. Alzheimers Dement 16:71\u201378","journal-title":"Alzheimers Dement"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1002\/alz.12643","article-title":"New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia","volume":"18","author":"Campo M","year":"2022","unstructured":"Del Campo M et al (2022) New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia. Alzheimers Dement 18:2292\u20132307","journal-title":"Alzheimers Dement"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"100065","DOI":"10.1016\/j.bionps.2023.100065","article-title":"Biomarkers in frontotemporal dementia: Current landscape and future directions","volume":"8","author":"Gifford A","year":"2023","unstructured":"Gifford A, Praschan N, Newhouse A, Chemali Z (2023) Biomarkers in frontotemporal dementia: Current landscape and future directions. Biomarkers Neuropsychiatry 8:100065","journal-title":"Biomarkers Neuropsychiatry"},{"key":"ref8","article-title":"New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures","author":"Boxer AL","year":"2019","unstructured":"Boxer AL et al (2019) New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures. Alzheimer's Dement","journal-title":"Alzheimer's Dement"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00415-019-09363-4","article-title":"An update on genetic frontotemporal dementia","volume":"266","author":"Greaves CV","year":"2019","unstructured":"Greaves CV, Rohrer JD (2019) An update on genetic frontotemporal dementia. J Neurol 266:2075\u20132086","journal-title":"J Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/s41591-022-01942-9","article-title":"Temporal order of clinical and biomarker changes in familial frontotemporal dementia","volume":"28","author":"Staffaroni AM","year":"2022","unstructured":"Staffaroni AM et al (2022) Temporal order of clinical and biomarker changes in familial frontotemporal dementia. Nat Med 28:2194\u20132206","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2019.02.006","article-title":"Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues","volume":"78","author":"Ferrari R","year":"2019","unstructured":"Ferrari R, Manzoni C, Hardy J (2019) Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues. Neurobiol Aging 78:98\u2013110","journal-title":"Neurobiol Aging"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","article-title":"C9orf72-mediated ALS and FTD: multiple pathways to disease","volume":"14","author":"Balendra R","year":"2018","unstructured":"Balendra R, Isaacs AM (2018) C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Reviews Neurol 14:544\u2013558","journal-title":"Nat Reviews Neurol"},{"key":"ref13","article-title":"C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy","volume":"12","author":"Cook CN","year":"2020","unstructured":"Cook CN et al (2020) C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy. Sci Transl Med 12","journal-title":"Sci Transl Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrn.2017.36","article-title":"Progranulin, lysosomal regulation and neurodegenerative disease","volume":"18","author":"Kao AW","year":"2017","unstructured":"Kao AW, McKay A, Singh PP, Brunet A, Huang EJ (2017) Progranulin, lysosomal regulation and neurodegenerative disease. Nat Rev Neurosci 18:325\u2013333","journal-title":"Nat Rev Neurosci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12031-011-9625-0","article-title":"TDP-43: mechanistic links and future directions","volume":"45","author":"Kumar-Singh S","year":"2011","unstructured":"Kumar-Singh S, Progranulin (2011) TDP-43: mechanistic links and future directions. J Mol Neurosci 45:561\u2013573","journal-title":"J Mol Neurosci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","article-title":"MAPT mutations, tauopathy, and mechanisms of neurodegeneration","volume":"99","author":"Strang KH","year":"2019","unstructured":"Strang KH, Golde TE, Giasson BI (2019) MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Lab Invest 99:912\u2013928","journal-title":"Lab Invest"},{"key":"ref17","author":"Schmidt S","year":"2022","unstructured":"Schmidt S, Holzer M, Arendt T, Sonntag M, Morawski M (2022) Tau Protein Modulates Perineuronal Extracellular Matrix Expression in the TauP301L-acan Mouse Model. Biomolecules 12"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cell.2021.12.041","article-title":"Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration","volume":"185","author":"Tracy TE","year":"2022","unstructured":"Tracy TE et al (2022) Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. Cell 185:712\u2013728e714","journal-title":"Cell"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41386-020-00840-3","article-title":"Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau","volume":"46","author":"Rayaprolu S","year":"2021","unstructured":"Rayaprolu S et al (2021) Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau. Neuropsychopharmacology 46:98\u2013115","journal-title":"Neuropsychopharmacology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","article-title":"Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level","volume":"25","author":"Johnson ECB","year":"2022","unstructured":"Johnson ECB et al (2022) Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat Neurosci 25:213\u2013225","journal-title":"Nat Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13195-022-01113-5","article-title":"Multi-platform proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome","volume":"14","author":"Dammer EB","year":"2022","unstructured":"Dammer EB et al (2022) Multi-platform proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome. Alzheimers Res Ther 14:174","journal-title":"Alzheimers Res Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","article-title":"Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation","volume":"26","author":"Johnson ECB","year":"2020","unstructured":"Johnson ECB et al (2020) Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med 26:769\u2013780","journal-title":"Nat Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"100607","DOI":"10.1016\/j.xcrm.2022.100607","article-title":"Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders","volume":"3","author":"Gendron TF","year":"2022","unstructured":"Gendron TF et al (2022) Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders. Cell Rep Med 3:100607","journal-title":"Cell Rep Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1038\/s41598-020-66090-x","article-title":"Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders","volume":"10","author":"Delaby C","year":"2020","unstructured":"Delaby C et al (2020) Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders. Sci Rep 10:9161","journal-title":"Sci Rep"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41531-023-00555-4","article-title":"Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson\u2019s disease","volume":"9","author":"Phillips B","year":"2023","unstructured":"Phillips B et al (2023) Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson\u2019s disease. npj Parkinson's Disease 9:107","journal-title":"npj Parkinson's Disease"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000002638","article-title":"Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes","volume":"86","author":"Coyle-Gilchrist IT","year":"2016","unstructured":"Coyle-Gilchrist IT et al (2016) Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology 86:1736\u20131743","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13024-023-00638-z","article-title":"Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer\u2019s disease","volume":"18","author":"Modeste ES","year":"2023","unstructured":"Modeste ES et al (2023) Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer\u2019s disease. Mol Neurodegener 18:48","journal-title":"Mol Neurodegener"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.15252\/emmm.201708202","article-title":"A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain","volume":"10","author":"Umoh ME","year":"2018","unstructured":"Umoh ME et al (2018) A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Mol Med 10:48\u201362","journal-title":"EMBO Mol Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13024-018-0282-4","article-title":"Deep proteomic network analysis of Alzheimer\u2019s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease","volume":"13","author":"Johnson ECB","year":"2018","unstructured":"Johnson ECB et al (2018) Deep proteomic network analysis of Alzheimer\u2019s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Mol Neurodegener 13:52","journal-title":"Mol Neurodegener"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41583-023-00717-6","article-title":"Alternative splicing in neurodegenerative disease and the promise of RNA therapies","volume":"24","author":"Nikom D","year":"2023","unstructured":"Nikom D, Zheng S (2023) Alternative splicing in neurodegenerative disease and the promise of RNA therapies. Nat Rev Neurosci 24:457\u2013473","journal-title":"Nat Rev Neurosci"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz9360","article-title":"Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease","volume":"6","author":"Higginbotham L","year":"2020","unstructured":"Higginbotham L et al (2020) Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease. Sci Adv 6","journal-title":"Sci Adv"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.celrep.2019.04.003","article-title":"Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons","volume":"27","author":"Liu EY","year":"2019","unstructured":"Liu EY et al (2019) Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons. Cell Rep 27:1409\u20131421e1406","journal-title":"Cell Rep"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev-pathmechdis-012418-012955","article-title":"RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration","volume":"14","author":"Hofmann JW","year":"2019","unstructured":"Hofmann JW, Seeley WW, Huang EJ (2019) RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration. Annu Rev Pathol 14:469\u2013495","journal-title":"Annu Rev Pathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-020-02203-0","article-title":"The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis","volume":"140","author":"Bampton A","year":"2020","unstructured":"Bampton A, Gittings LM, Fratta P, Lashley T, Gatt A (2020) The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis. Acta Neuropathol 140:599\u2013623","journal-title":"Acta Neuropathol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/brain\/awy062","article-title":"TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis","volume":"141","author":"Deshaies J-E","year":"2018","unstructured":"Deshaies J-E et al (2018) TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis. Brain 141:1320\u20131333","journal-title":"Brain"},{"key":"ref36","author":"Irwin KE","year":"2023","unstructured":"Irwin KE et al (2023), A fluid biomarker reveals loss of TDP-43 splicing repression in pre-symptomatic ALS. bioRxiv"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1212\/WNL.0000000000004569","article-title":"Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers","volume":"89","author":"Casaletto KB","year":"2017","unstructured":"Casaletto KB et al (2017) Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers. Neurology 89:1782\u20131788","journal-title":"Neurology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/s41467-019-09613-z","article-title":"Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age","volume":"10","author":"Wingo AP","year":"2019","unstructured":"Wingo AP et al (2019) Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age. Nat Commun 10:1619","journal-title":"Nat Commun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1177271920950319","DOI":"10.1177\/1177271920950319","article-title":"Fluid Biomarkers for Synaptic Dysfunction and Loss","volume":"15","author":"Camporesi E","year":"2020","unstructured":"Camporesi E et al (2020) Fluid Biomarkers for Synaptic Dysfunction and Loss. Biomark Insights 15:1177271920950319","journal-title":"Biomark Insights"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41582-019-0222-0","article-title":"SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases","volume":"15","author":"Paterson RW","year":"2019","unstructured":"Paterson RW et al (2019) SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases. Nat Rev Neurol 15:419\u2013427","journal-title":"Nat Rev Neurol"},{"key":"ref41","author":"Boiten WA","year":"2020","unstructured":"Boiten WA et al (2020) Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF. Cells 10"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/alz.12353","article-title":"Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease","volume":"17","author":"Libiger O","year":"2021","unstructured":"Libiger O et al (2021) Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease. Alzheimers Dement 17:1976\u20131987","journal-title":"Alzheimers Dement"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/jnnp-2019-322493","article-title":"Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia","volume":"91","author":"Ende EL","year":"2020","unstructured":"van der Ende EL et al (2020) Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia. J Neurol Neurosurg Psychiatry 91:612\u2013621","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.euroneuro.2012.07.017","article-title":"KCNIP4 as a candidate gene for personality disorders and adult ADHD","volume":"23","author":"Wei\u00dfflog L","year":"2013","unstructured":"Wei\u00dfflog L et al (2013) KCNIP4 as a candidate gene for personality disorders and adult ADHD. Eur Neuropsychopharmacol 23:436\u2013447","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1042\/BST0380445","article-title":"Confirmed rare copy number variants implicate novel genes in schizophrenia","volume":"38","author":"Tam GW","year":"2010","unstructured":"Tam GW et al (2010) Confirmed rare copy number variants implicate novel genes in schizophrenia. Biochem Soc Trans 38:445\u2013451","journal-title":"Biochem Soc Trans"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/ana.26738","article-title":"Network Connectivity Alterations across the MAPT Mutation Clinical Spectrum","volume":"94","author":"Zhang L","year":"2023","unstructured":"Zhang L et al (2023) Network Connectivity Alterations across the MAPT Mutation Clinical Spectrum. Ann Neurol 94:632\u2013646","journal-title":"Ann Neurol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.nicl.2016.12.006","article-title":"Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers","volume":"14","author":"Lee SE","year":"2017","unstructured":"Lee SE et al (2017) Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers. Neuroimage Clin 14:286\u2013297","journal-title":"Neuroimage Clin"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41380-021-01384-8","article-title":"Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration\u2014Insights into disease mechanisms and current therapeutic approaches","volume":"27","author":"Huber N","year":"2022","unstructured":"Huber N et al (2022) Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration\u2014Insights into disease mechanisms and current therapeutic approaches. Mol Psychiatry 27:1300\u20131309","journal-title":"Mol Psychiatry"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fncel.2020.00035","article-title":"Transcription and Beyond: Delineating FOXG1 Function in Cortical Development and Disorders","volume":"14","author":"Hou PS","year":"2020","unstructured":"Hou PS, hAil\u00edn D, Vogel T, Hanashima C (2020) Transcription and Beyond: Delineating FOXG1 Function in Cortical Development and Disorders. Front Cell Neurosci 14:35","journal-title":"Front Cell Neurosci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/jcp.25498","article-title":"Neuronatin Protein in Health and Disease","volume":"232","author":"Pitale PM","year":"2017","unstructured":"Pitale PM, Howse W, Gorbatyuk M (2017) Neuronatin Protein in Health and Disease. J Cell Physiol 232:477\u2013481","journal-title":"J Cell Physiol"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911085","article-title":"The Role of Extracellular Matrix in Human Neurodegenerative Diseases","volume":"23","author":"Pint\u00e9r P","year":"2022","unstructured":"Pint\u00e9r P, Alp\u00e1r A (2022) The Role of Extracellular Matrix in Human Neurodegenerative Diseases. Int J Mol Sci 23","journal-title":"Int J Mol Sci"},{"key":"ref52","article-title":"Glia, Extracellular Matrix and Neurovascular Unit: A Systems Biology Approach to the Complexity of Synaptic Plasticity in Health and Disease","volume":"21","author":"Luca C","year":"2020","unstructured":"De Luca C, Colangelo AM, Virtuoso A, Alberghina L, Papa M, Neurons (2020) Glia, Extracellular Matrix and Neurovascular Unit: A Systems Biology Approach to the Complexity of Synaptic Plasticity in Health and Disease. Int J Mol Sci 21","journal-title":"Int J Mol Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/s41591-023-02476-4","article-title":"Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer\u2019s disease","volume":"29","author":"Johnson ECB","year":"2023","unstructured":"Johnson ECB et al (2023) Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer\u2019s disease. Nat Med 29:1979\u20131988","journal-title":"Nat Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"844211","DOI":"10.3389\/fncel.2022.844211","article-title":"The role of extracellular matrix components in the spreading of pathological protein aggregates","volume":"16","author":"Moretto E","year":"2022","unstructured":"Moretto E, Stuart S, Surana S, Vargas JNS, Schiavo G (2022) The role of extracellular matrix components in the spreading of pathological protein aggregates. Front Cell Neurosci 16:844211","journal-title":"Front Cell Neurosci"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"19855","DOI":"10.1074\/jbc.R114.549295","article-title":"Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target","volume":"289","author":"Holmes BB","year":"2014","unstructured":"Holmes BB, Diamond MI (2014) Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target. J Biol Chem 289:19855\u201319861","journal-title":"J Biol Chem"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jalz.2019.06.4951","article-title":"Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay","volume":"15","author":"Shi L","year":"2019","unstructured":"Shi L et al (2019) Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay. Alzheimer's Dement 15:1478\u20131488","journal-title":"Alzheimer's Dement"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","article-title":"Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders","volume":"24","author":"Yang C","year":"2021","unstructured":"Yang C et al (2021) Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat Neurosci 24:1302\u20131312","journal-title":"Nat Neurosci"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/alz.12011","article-title":"Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases","volume":"16","author":"Ramos EM","year":"2020","unstructured":"Ramos EM et al (2020) Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases. Alzheimers Dement 16:118\u2013130","journal-title":"Alzheimers Dement"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jalz.2019.06.4947","article-title":"The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology","volume":"16","author":"Boeve B","year":"2020","unstructured":"Boeve B et al (2020) The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology. Alzheimer's Dement 16:22\u201336","journal-title":"Alzheimer's Dement"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jalz.2010.12.006","article-title":"Language and behavior domains enhance the value of the clinical dementia rating scale","volume":"7","author":"Knopman DS","year":"2011","unstructured":"Knopman DS, Weintraub S, Pankratz VS (2011) Language and behavior domains enhance the value of the clinical dementia rating scale. Alzheimer's Dement 7:293\u2013299","journal-title":"Alzheimer's Dement"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/brain\/awn234","article-title":"Development of methodology for conducting clinical trials in frontotemporal lobar degeneration","volume":"131","author":"Knopman DS","year":"2008","unstructured":"Knopman DS et al (2008) Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain 131:2957\u20132968","journal-title":"Brain"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/alz.12033","article-title":"Utility of the global CDR(\u00ae) plus NACC FTLD rating and development of scoring rules: Data from the ARTFL\/LEFFTDS Consortium","volume":"16","author":"Miyagawa T","year":"2020","unstructured":"Miyagawa T et al (2020) Utility of the global CDR(\u00ae) plus NACC FTLD rating and development of scoring rules: Data from the ARTFL\/LEFFTDS Consortium. Alzheimers Dement 16:106\u2013117","journal-title":"Alzheimers Dement"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1038\/mtna.2014.49","article-title":"Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents","volume":"3","author":"Rohloff JC","year":"2014","unstructured":"Rohloff JC et al (2014) Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents. Mol Ther Nucleic Acids 3:e201","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold L","year":"2010","unstructured":"Gold L et al (2010) Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 5:e15004","journal-title":"PLoS ONE"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder P","year":"2008","unstructured":"Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9:559","journal-title":"BMC Bioinformatics"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","article-title":"Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap","volume":"14","author":"Reimand J","year":"2019","unstructured":"Reimand J et al (2019) Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nat Protoc 14:482\u2013517","journal-title":"Nat Protoc"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/WAD.0000000000000223","article-title":"Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS)","volume":"32","author":"Weintraub S","year":"2018","unstructured":"Weintraub S et al (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10\u201317","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/alz.13454","article-title":"Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults","volume":"20","author":"Saloner R","year":"2024","unstructured":"Saloner R et al (2024) Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults. Alzheimer's Dement 20:376\u2013387","journal-title":"Alzheimer's Dement"},{"key":"ref69","author":"Linda K","year":"2023","unstructured":"Linda K et al (2023), Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases. bioRxiv, 2023.2006.2008.544222"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00259-022-06065-4","article-title":"[18F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes","volume":"50","author":"Santillo AF","year":"2023","unstructured":"Santillo AF et al (2023) [18F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes. Eur J Nucl Med Mol Imaging 50:1371\u20131383","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"e1001057","DOI":"10.1371\/journal.pcbi.1001057","article-title":"Is my network module preserved and reproducible?","volume":"7","author":"Langfelder P","year":"2011","unstructured":"Langfelder P, Luo R, Oldham MC, Horvath S (2011) Is my network module preserved and reproducible? PLoS Comput Biol 7:e1001057","journal-title":"PLoS Comput Biol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4103685\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4103685\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T07:11:38Z","timestamp":1747465898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4103685\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":71,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4103685\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s43587-025-00878-2","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,3,28]]},"subtype":"preprint"}}